Fireside Chat: Examining the Future of Tumour Modelling
- Hybrid submissions – will they become the new standard or the new normal?
- Balancing in vivo versus in vitro and 3D in model selection
- Debunking the role of in vivo models and non-animal tests to inform future clinical trial design